This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Methylphenidate: Difference between revisions
>Benzofury m Cocaine interaction was placed twice because of MAOIs transclusion. Minor edit removed the second occurence. |
>PNWhedonist mNo edit summary |
||
| Line 2: | Line 2: | ||
{{SubstanceBox/Methylphenidate}} | {{SubstanceBox/Methylphenidate}} | ||
'''Methylphenidate''' (also known as '''MPH''', '''MPD''', and its brand names '''Ritalin''', '''Concerta''', and '''Methylin''', among others) is [[psychoactive class::stimulant]] substance of the [[chemical class::phenidate]] class. Methylphenidate is the parent compound of the [[substituted phenidates]], a family of compounds that includes [[ethylphenidate]], [[isopropylphenidate]], and others. It acts primarily by enhancing the activity of the [[neurotransmitters]] [[dopamine]] and [[norepinephrine]] in the brain. | '''Methylphenidate''' (also known as '''MPH''', '''MPD''', and its brand names '''Ritalin''', '''Concerta''', and '''Methylin''', among others) is a [[psychoactive class::stimulant]] substance of the [[chemical class::phenidate]] class. Methylphenidate is the parent compound of the [[substituted phenidates]], a family of compounds that includes [[ethylphenidate]], [[isopropylphenidate]], and others. It acts primarily by enhancing the activity of the [[neurotransmitters]] [[dopamine]] and [[norepinephrine]] in the brain. | ||
Methylphenidate was first licensed by the U.S. Food and Drug Administration (FDA) in 1955 for treating what was then known as "hyperactivity." Although it was prescribed to patients as early as 1960, it only became heavily prescribed in the 1990s when the diagnosis of ADHD itself became more widely accepted.<ref>Diller, Lawrence (1999). Running on Ritalin. ISBN 978-0553379068.</ref><ref>The history of attention deficit hyperactivity disorder (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907/</ref> | Methylphenidate was first licensed by the U.S. Food and Drug Administration (FDA) in 1955 for treating what was then known as "hyperactivity." Although it was prescribed to patients as early as 1960, it only became heavily prescribed in the 1990s when the diagnosis of ADHD itself became more widely accepted.<ref>Diller, Lawrence (1999). Running on Ritalin. ISBN 978-0553379068.</ref><ref>The history of attention deficit hyperactivity disorder (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907/</ref> | ||